This study investigated the effects of chronic arsenic exposure on QT- and QTc-interval prolongation, QTc dispersion (QTcd) and transmural dispersion of repolarization (TDR). We compared cardiac parameters from 40 male subjects chronically exposed to arsenic (group A) with those of 40 male subjects not exposed to arsenic (group B). Although subjects in both groups had non-corrected QT intervals within normal limits, subjects in group A had significantly longer QTc and QTcd intervals compared with group B. A total of 70% of group A compared with 10% of group B had QTcd values > 50 ms. The mean TDR value was also significantly higher in group A compared with group B. Although non-corrected QT intervals were within normal limits, those subjects chronically exposed to arsenic had a slight QT prolongation and a higher prevalence of subtle repolarization abnormalities, which might be clinically relevant.
IshinishiNTsuchiyaKVahterM: Arsenic. In: Handbook of the Toxicology of Metals, Vol II (FriebergLNordbergGFVoukBV, eds). Amsterdam: Elsevier, 1986; pp 43–73.
2.
DeMariniDMKligermanADDoerrCL: Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations. Environ Mol Mutagen2003; 42: 192–205.
3.
World Health Organization: Environmental Health Criteria 18, Arsenic. Geneva: World Health Organization, 1981; pp 43–102.
4.
US Environmental Protection Agency: National Primary Drinking Water Standards. Washington: US Environmental Protection Agency, Office of Water (4606M) EPA 816-F-03–016, June 2003.
5.
TsengWP: Effects and dose—response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect1977; 19: 109–119.
6.
RossR: The pathogenesis of atherosclerosis: An update. N Engl J Med1986; 314: 488–500.
7.
ChenCJChiouHYChiangMH: Dose—response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol1996; 16: 504–510.
8.
ChiouHYHuangWISuCL: Dose—response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke1997; 28: 1717–1723.
9.
AhmadSAKhatunFSayedMH: Electrocardiographic abnormalities among arsenic-exposed persons through groundwater in Bangladesh. J Health Popul Nutr2006; 24: 221–227.
10.
ChangCCHoSCTsaiSS: Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system. Toxicol Environ Health2004; 67: 1353–1361.
11.
Navas-AcienASharrettARSilbergeldEK: Arsenic exposure and cardiovascular disease: A systematic review of the epidemiologic evidence. Am J Epidemiol2006; 164: 194–195; author reply 195–196.
12.
YuHSLiaoWTChaiCY: Arsenic carcinogenesis in the skin. J Biomed Sci2006; 13: 657–666.
13.
SmithAHMarshallGYuanY: Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect2006; 114: 1293–1296.
14.
TsengWP: Effects and dose—response relationship of skin cancer and blackfoot disease with arsenic. Environ Health Perspect1977; 19: 109–119.
15.
OhnishiKYoshidaHShingenoK: Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med2000; 133: 881–885.
16.
UnnikrishnanDDutcherJPVarshneyaN: Torsades de pointes in 3 patients with leukemia treated with arsenic poisoning. Blood2001; 97: 1514–1516.
17.
LittleREKayGNCavenderJB: Torsade de pointes and T-U wave alternans associated with arsenic poisoning. Pacing Clin Electrophysiol1990; 13: 164–170.
18.
RodriguezIKilbornMJLiuX: Drug-induced QT prolongation in women during the menstrual cycle. JAMA2001; 285: 1322–1326.
19.
ACME Analytical Laboratories: Methods and Specifications for Analytical Package. Group 2C & 2D—Water Analysis by ICP-MS, 2005.
20.
American Public Health Association: Standard Methods for the Examination of Water and Wastewater. Washington DC: American Public Health Association, 1992.
21.
BazzetHC: An analysis of the time-relations of electrocardiograms. Heart1920; 7: 353–370.
22.
World Health Organization: Health criteria and other supporting information. Guidelines for Drinking-water Quality, 2nd edn.Geneva: World Health Organization, 1996; pp 940–949.
23.
FickerEKuryshevYADennisAT: Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol2004; 66: 33–44.
24.
MumfordJLWuKXiaY: Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ Health Perspect2007; 115: 690–694.
25.
EngströmSKBrobergKGabrielaC: Genetic polymorphism influencing arsenic metabolism: Evidence from Argentina. Environ Health Perspect2007; 115: 599–605.
26.
AntzelevitchC: T peak—T end interval as an index of transmural dispersion of repolarization. Eur J Clin Invest2001; 31: 555–557.
TanabeYInagakiMKuritaT: Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol2001; 37: 911–919.
29.
FrederiksJSwenneCAKorsJA: Within-subject electrocardiographic differences at equal heart rates: Role of the autonomic nervous system. Pflugers Arch2001; 441: 717–724.
30.
ShimizuMInoHOkeieK: T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol2002; 25: 335–339.
31.
TakenakaKAiTShimizuW: Exercise stress test amplifies genotype—phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation2003; 107: 838–844.
32.
WatanabeNKobayashiYTannoK: Transmural dispersion of repolarization and ventricular tachyarrhythmias. J Electrocardiol2004; 37: 191–200.
